# PP-0199 — Lymphadenectomy

## QA Report

**QA ID:** QA-PP-0199  
**PP ID:** PP-0199  
**Version:** 1.0.0  
**QA Status:** PASS — GOLD — READY FOR INTEGRATION

---

# 1. QA Executive Summary

PP-0199 was produced after the Project Coordinator approved and locked the complete Decision Batch.

The package was built using:

- locked governance;
- Gold Population Package Specification;
- approved Discussion Batch format/depth reference;
- supplied gastric-cancer Source Materials;
- approved adjacent-package boundaries.

The package contains all four required artifacts:

1. Clinical Knowledge Object;
2. Knowledge Passport;
3. Primary Evidence Package;
4. QA Report.

No architecture blocker was identified.

---

# 2. Layer 1 — Content QA

## 2.1 Scope integrity

**PASS**

The package answers one atomic question:

> What is lymphadenectomy in gastric cancer, why is it performed, how is its extent described, and why do extent, node yield, nodal positivity and expertise matter?

No unrelated treatment package has been absorbed.

---

## 2.2 Completeness

**PASS**

The package covers:

- definition;
- rationale;
- regional spread;
- oncologic role;
- staging role;
- gastrectomy relationship;
- D0;
- D1;
- D1+;
- D2;
- D2+;
- ≥16-node goal;
- node yield;
- positive nodes;
- N staging;
- skip metastasis;
- D1/D2 evidence;
- regional practice;
- expertise;
- spleen/pancreas preservation;
- curative/palliative distinction;
- patient-facing questions.

---

## 2.3 Atomicity

**PASS**

The package does not become:

- a gastrectomy package;
- a D1 package;
- a D2 package;
- a sentinel-node package;
- a treatment-by-stage package.

---

# 3. Layer 1 — Boundary QA

## 3.1 D1 overlap

**PASS**

PP-0199 introduces D1 conceptually.

Detailed D1 ownership is delegated to PP-0200.

---

## 3.2 D2 overlap

**PASS**

PP-0199 introduces D2 conceptually.

Detailed D2 ownership is delegated to PP-0201.

---

## 3.3 Sentinel-node overlap

**PASS**

Sentinel lymph node is treated only as a related strategy.

Detailed sentinel-node methodology is delegated to PP-0202.

---

## 3.4 Gastrectomy overlap

**PASS**

Gastrectomy is used as surgical context.

Detailed subtotal/total gastrectomy remains delegated to PP-0197/PP-0198.

---

## 3.5 Treatment overlap

**PASS**

No chemotherapy, immunotherapy, radiation or targeted-therapy algorithm is embedded.

---

# 4. Layer 2 — Clinical QA

## 4.1 Guideline alignment

**PASS**

Core surgical claims are aligned with supplied NCCN material.

---

## 4.2 NCI alignment

**PASS**

NCI is used for:

- regional lymphadenectomy with gastric resection;
- stage context;
- D2 uncertainty;
- morbidity context;
- nodal staging.

---

## 4.3 Vietnamese guideline alignment

**PASS**

The Vietnamese source is used for:

- D1/D1+/D2/D2+ terminology;
- nodal station orientation;
- stage-linked examples;
- skip metastasis.

The regional guideline is not silently converted into a universal global rule.

---

## 4.4 ACS alignment

**PASS**

ACS is used as patient-facing supporting material.

---

# 5. Critical Clinical Safety Audit

## Check 1 — Does the package claim D2 is always better?

**NO — PASS**

The package explicitly states that greater extent does not automatically mean better outcomes.

---

## Check 2 — Does the package equate ≥16 nodes with D2?

**NO — PASS**

The distinction is explicitly repeated.

---

## Check 3 — Does the package equate node yield with positive-node count?

**NO — PASS**

The three dimensions are separated.

---

## Check 4 — Does the package imply routine splenectomy?

**NO — PASS**

The package explicitly states that routine splenectomy is not recommended.

---

## Check 5 — Does the package imply routine pancreatectomy?

**NO — PASS**

The package explicitly states that routine prophylactic pancreatectomy is not recommended.

---

## Check 6 — Does the package turn palliative surgery into curative surgery?

**NO — PASS**

Curative and palliative contexts are explicitly separated.

---

## Check 7 — Does the package give individualized treatment?

**NO — PASS**

No individualized treatment recommendation is provided.

---

## Check 8 — Does the package provide operative instructions?

**NO — PASS**

Detailed surgical technique is excluded.

---

## Check 9 — Does the package provide individualized prognosis?

**NO — PASS**

Prognostic relevance is explained without individual prediction.

---

# 6. Evidence Traceability QA

| Evidence domain | Source | Traceability | Result |
|---|---|---|---|
| Definition | NCCN/NCI | Explicit | PASS |
| Regional lymphadenectomy | NCCN/NCI | Explicit | PASS |
| D0/D1/D2 | NCCN | Explicit | PASS |
| D1+/D2+ | Vietnamese guideline | Explicit | PASS |
| ≥16 nodes | NCCN | Explicit | PASS |
| N category | NCI | Explicit | PASS |
| D2 expertise | NCCN | Explicit | PASS |
| D2 evidence uncertainty | NCCN/NCI | Explicit | PASS |
| Splenectomy | NCCN | Explicit | PASS |
| Pancreatectomy | NCCN | Explicit | PASS |
| Palliative lymphadenectomy | NCCN | Explicit | PASS |
| Patient explanation | ACS | Explicit/supporting | PASS |

---

# 7. Source Conflict / Granularity Audit

## Issue

Different sources describe D1/D2 at different anatomical levels.

### Resolution

**PASS**

The package preserves the existence of the classifications without pretending that every source uses identical station terminology.

Detailed station ownership is delegated.

---

# 8. Historical Evidence Calibration

## Risk

Older D2 studies may be interpreted as directly equivalent to modern high-volume D2 practice.

### Control

The package explicitly describes historical Western trial findings as historical/contextual evidence and emphasizes modern expertise.

### Result

**PASS**

---

# 9. Patient-Safety QA

| Safety question | Result |
|---|---|
| Could a patient think D2 is mandatory for everyone? | PASS — no |
| Could a patient think 16 nodes means D2? | PASS — corrected |
| Could a patient think negative nodes mean cure? | PASS — corrected |
| Could a patient think D2 means spleen removal? | PASS — corrected |
| Could a patient think D2 means pancreas removal? | PASS — corrected |
| Could a patient think palliative surgery requires D2? | PASS — corrected |
| Could a patient infer treatment from N category alone? | PASS — treatment delegated |
| Could a patient receive a personalized surgical recommendation? | PASS — not provided |
| Could a patient receive operative instructions? | PASS — excluded |

---

# 10. Educational QA

## Plain language

**PASS**

Medical terms such as lymphadenectomy, regional lymph nodes, D1, D2 and N category are explained in context.

## One concept per paragraph

**PASS**

The CKO uses short conceptual blocks.

## Patient-facing questions

**PASS**

The package includes multiple patient scenarios and questions.

## Misconception correction

**PASS**

Common misunderstandings are explicitly addressed.

## Neutral tone

**PASS**

No sensational or coercive language is used.

## Unsupported certainty

**PASS**

Context-dependent statements are qualified.

---

# 11. Knowledge Graph QA

## Prerequisites

**PASS**

PP-0042, PP-0044 and gastrectomy packages are identified.

## Related packages

**PASS**

Endoscopic resection, D1, D2, sentinel-node and pathology/staging relationships are represented.

## Downstream

**PASS**

D1/D2/sentinel-node and treatment pathways are represented without absorbing their ownership.

---

# 12. Runtime Retrieval QA

## Query: “What is lymphadenectomy?”

Expected target:

→ PP-0199.

**PASS**

## Query: “What is D1?”

Expected:

→ PP-0199 for orientation; PP-0200 for depth.

**PASS**

## Query: “What are D2 lymph-node stations?”

Expected:

→ PP-0201.

**PASS**

## Query: “Does D2 mean 16 lymph nodes?”

Expected:

→ PP-0199 misconception correction.

**PASS**

## Query: “What does N2 mean?”

Expected:

→ PP-0044, with PP-0199 as supporting context.

**PASS**

## Query: “What chemotherapy do I need because I have N2 disease?”

Expected:

→ treatment-specific PP, not PP-0199.

**PASS**

---

# 13. Cross-Artifact Consistency Audit

| Topic | CKO | KP | EP | QA | Result |
|---|---|---|---|---|---|
| Definition | Yes | Yes | Yes | Verified | PASS |
| Regional nodes | Yes | Yes | Yes | Verified | PASS |
| D0/D1/D2 | Yes | Yes | Yes | Verified | PASS |
| D1+/D2+ | Yes | Yes | Yes | Verified | PASS |
| ≥16 nodes | Yes | Yes | Yes | Verified | PASS |
| Positive nodes | Yes | Yes | Yes | Verified | PASS |
| Expertise | Yes | Yes | Yes | Verified | PASS |
| Spleen/pancreas | Yes | Yes | Yes | Verified | PASS |
| Palliative context | Yes | Yes | Yes | Verified | PASS |
| Adjacent PP boundary | Yes | Yes | Yes | Verified | PASS |

---

# 14. Governance QA

## Gold specification

**PASS**

Four required artifacts are present.

## Gold depth

**PASS**

The artifacts are intentionally comprehensive and not compacted.

## Source-first

**PASS**

Project Source Files were searched before production.

## Locked Decision

**PASS**

The approved Decision Batch is treated as locked.

## Naming

**PASS**

Package name contains PP number and title.

## Boundary

**PASS**

Boundary is prepared in the required four-part format for the final production response.

## QA status

**PASS**

Standard final status is used.

---

# 15. Red-Team Failure Modes

## Failure Mode 1 — PP-0199 becomes a D2 package

**Control:** D2 detail delegated to PP-0201.

**Result:** PASS.

## Failure Mode 2 — PP-0199 becomes a D1 package

**Control:** D1 detail delegated to PP-0200.

**Result:** PASS.

## Failure Mode 3 — Node count is treated as anatomical extent

**Control:** Extent/yield/positivity explicitly separated.

**Result:** PASS.

## Failure Mode 4 — More extensive surgery is treated as automatically better

**Control:** Evidence-calibrated benefit–risk explanation.

**Result:** PASS.

## Failure Mode 5 — Historical D2 evidence is overgeneralized

**Control:** Historical versus modern context distinguished.

**Result:** PASS.

## Failure Mode 6 — D2 is equated with splenectomy

**Control:** NCCN organ-preservation statement.

**Result:** PASS.

## Failure Mode 7 — D2 is equated with pancreatectomy

**Control:** NCCN statement against routine prophylactic pancreatectomy.

**Result:** PASS.

## Failure Mode 8 — Palliative surgery is treated as curative surgery

**Control:** Separate curative and palliative logic.

**Result:** PASS.

## Failure Mode 9 — Lymphadenectomy becomes a treatment-selection algorithm

**Control:** Treatment packages delegated.

**Result:** PASS.

## Failure Mode 10 — Individual prognosis is generated from node findings

**Control:** Prognostic interpretation remains general.

**Result:** PASS.

---

# 16. Unsupported-Claim Scan

| Potential unsupported claim | Present? | QA |
|---|---|---|
| D2 is always superior | No | PASS |
| ≥16 nodes defines D2 | No | PASS |
| D2 always requires splenectomy | No | PASS |
| D2 always requires pancreatectomy | No | PASS |
| Node-negative means cured | No | PASS |
| Node count alone defines stage | No | PASS |
| Lymphadenectomy guarantees cure | No | PASS |
| Personalized surgery recommendation | No | PASS |
| Personalized chemotherapy | No | PASS |
| Detailed operative technique | No | PASS |

---

# 17. Boundary Stress Test

## PP-0196 — Gastrectomy Principles

Question:

“Should the patient have a subtotal or total gastrectomy?”

### Routing

PP-0196/PP-0197/PP-0198.

**PASS**

---

## PP-0200 — D1

Question:

“Which exact nodal stations are included in D1?”

### Routing

PP-0200.

**PASS**

---

## PP-0201 — D2

Question:

“Which exact nodal stations and operative fields constitute D2?”

### Routing

PP-0201.

**PASS**

---

## PP-0202 — Sentinel Lymph Node

Question:

“How is sentinel-node mapping performed?”

### Routing

PP-0202.

**PASS**

---

## Treatment PPs

Question:

“What chemotherapy should I receive because lymph nodes are positive?”

### Routing

Treatment-specific package.

**PASS**

---

# 18. Repository Integrity

Required artifact names:

```text
01_CKO.md
02_KNOWLEDGE_PASSPORT.md
03_PRIMARY_EVIDENCE_PACKAGE.md
04_QA_REPORT.md
```

**PASS**

Package directory:

```text
PP-0199_Lymphadenectomy_GOLD_v1.0.0/
```

**PASS**

ZIP filename:

```text
PP-0199_Lymphadenectomy_GOLD_v1.0.0.zip
```

**PASS**

---

# 19. Final QA Assessment

## Content QA

**PASS**

## Clinical QA

**PASS**

## Educational QA

**PASS**

## Governance QA

**PASS**

## Evidence Traceability

**PASS**

## Boundary Integrity

**PASS**

## Knowledge Graph Integrity

**PASS**

## Gold Depth Integrity

**PASS**

---

# 20. Final Decision

# PASS — GOLD — READY FOR INTEGRATION

---

# 21. Revision History

| Version | Date | Summary |
|---|---|---|
| 1.0.0 | 2026-08-09 | Initial Gold QA after approved and locked PP-0199 Decision Batch. |
